CD274 and prostate adenocarcinoma: Apart from the correlation observed between both receptors and PD-L1, the authors analyzed the association with co-inhibitor immune checkpoint inhibitors, detecting only a moderate correlation (Rho = 0.460, p = 3.21 × 10−23) between MET and HAVCR2 in PRAD (Figure 6C).